Abstract
Alginate is used as a matrix for immunoisolation of cells and tissues in vivo. We have demonstrated previously that commercial alginates contain various fractions of mitogenic impurities and that they can be removed by free flow electrophoresis. The use of purified material is a necessity in order to reveal the parameters that control biocompatibility of the implanted material (such as stability, size, surface charge and curvature, etc.). In this study, we present a protocol for the chemical purification of alginates on a large-scale. Beads made from alginates purified by this multi-step chemical extraction procedure did not induce a significant foreign body reaction when implanted for 3 weeks either intraperitoneally or beneath the kidney capsule of Lewis or non-diabetic BB/Gi rats.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cai ZH (1989) Microencapsulated hepatocytes for bioarteficial liver support. Artif Organs 12:388–393
Calafiore R (1992) Transplantation of microencapsulated pancreatic human islets for therapy of diabetes mellitus. A preliminary report. ASAIO Trans 38:34–37
Clayton HA, London NJ, Colloby PS, Bell PR, James RF (1991) The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules. J Microencapsulation 8:221–233
Cole DR, Waterfall M, McIntyre M, Smith W, Baird JD (1989) Transplantation of microencapsulated pancreatic islets in BB/E diabetic rats. Mechanism of graft failure. Diabetologia 35:231–237
Dainty AL, Goulding KH, Robinson PK, Simpkins I, Trevan MD (1986) Stability of alginate immobilized algal cells. Biotechnol Bioeng 28:210–216
Darqui S, Sun AM (1987) Microencapsulation of parathyroid cells as a bioarteficial parathyroid. In vitro studies. ASAIO Trans 33:356–358
Geisen K, Deutschländer H, Gorbach S, Klenke C, and Zimmermann U (1990) Function of barium alginate-microencapsulated xenogenic islets in different diabetic mouse models. In: Shafrir E (ed) Frontiers in diabetes research. Lessons from animal diabetes III.II.8:142–148
Hansen BM, Nielsen SE, Berg K (1988) Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203–210
Klein J, Stock J, Vorlop KD (1983) Pore size and properties of spherical Ca alginate biocatalysts. Eur J Microbiol Biotechnol 18:86–91
Lim F, Sun A (1980) Microencapsulated islets as bioarteficial pancreas. Science 210:908–910
Lum ZO, Tai IT, Krestow M, Norton J, Vacek I, Sun AM (1992) Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 40:1511–1516
Mazaheri R, Atkinson P, Stiller C, Dupre J, Vose J, O'Shea G (1991) Transplantation of encapsulated allogenic islets into diabetic BB/W rats. Transplantation 51:750–754
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Otterlei M, Ostgaard K, Skjaek-Braek G, Smidsrod O, Soon-Shiong P, Espevik T (1991) Induction of cytokine production from human monocytes stimulated with alginate. J Immunotherapy 10:286–291
Rehm HJ, Reed G (eds) (1987) Biotechnology, vol 7a. VCH, Weinheim
Scheer R (1988) Pyrogene and Limulustest. Pharm Unserer Zeit 5:137–146
Schnabl H, Zimmermann U (1989) Immobilization of plant protoplasts. In: Bajay YPS (ed) Plant protoplasts and genetic engineering, vol 1. Springer, Berlin Heidelberg New York, pp 63–96
Simpson JA, Smith SE, Dean RT (1988) Alginate inhibition of the uptake of Pseudomonas aeruginosa by alginates. J Gen Microbiol 134:29–36
Skjaek-Braek G, Murano E, Poaletti S (1989) Alginate as immobilization material. II: Determination of polyphenolic contaminants by fluorescence spectroscopy and evaluation of methods for their removal. Biotechnol Bioeng 33:90–94
Tanaka H, Irie S (1988) Preparation of stable alginate gel beads in electrolyte solutions using Ba2+ and Sr2+. Biotechnol Tech 2:115–120
Trompkins R, Carter EA, Carlson JD, Yarmush ML (1988) Enzymatic function of alginate immobilized rat hepatocytes. Biotechnol Bioeng 31:495–499
Turner TD, Spyratou O, Schmidt RJ (1989) Biocompatibility of wound management products: standardization of and determination of cell growth rate in L929 fibroblast cultures. J Pharm Pharmacol 41:775–780
Zekorn T, Horcher A, Siebers U, Schnettler R, Klöck G, Hering B, Zimmermann U, Bretzel RG, Federlin K (1992a) Bariumcross-linked alginate beads: a simple one-step method for succesful immuno-isolated transplantation of islets of Langerhans. Acta Diabetol 29:99–106
Zekorn T, Siebers U, Horcher A, Zimmermann U, Bretzel RG, Federlin K (1992b) Alginate coating of islets. A new technique for microencapsulation. Acta Diabetol 29:1–5
Zimmermann U, Klöck G, Federlin K, Hannig K, Kowalski M, Bretzel RG, Horcher A, Entenmann H, Siebers U, Zekorn T (1992) Production of mitogen contamination free alginates with variable rations of mannuronic to guluronic acid by free flow electrophoresis. Electrophoresis 13:269–274
Author information
Authors and Affiliations
Additional information
Correspondence to: U. Zimmermann
Rights and permissions
About this article
Cite this article
Klöck, G., Frank, H., Houben, R. et al. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 40, 638–643 (1994). https://doi.org/10.1007/BF00173321
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173321